* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Advanced Cardiac Life Support 2000
Survey
Document related concepts
Coronary artery disease wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Myocardial infarction wikipedia , lookup
Jatene procedure wikipedia , lookup
Electrocardiography wikipedia , lookup
Cardiac arrest wikipedia , lookup
Atrial fibrillation wikipedia , lookup
Heart arrhythmia wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Transcript
Advanced Cardiac Life Support 2004 Mark I. Langdorf, MD, MHPE, FACEP Professor or Clinical Emergency Medicine Chair and Associate Residency Director University of California, Irvine ACLS History • Sixth iteration of guidelines since 1966 • Second that is evidence based • First that incorporates international perspective Evidence Based Guidelines • • • • Search the international literature Determine level of each piece of evidence Graded each study for quality Integrate all evidence into final class recommendation Classes of Recommendations • Class I: always acceptable, proven safe and • • • • definitely useful Class IIa: acceptable, reasonably prudent, intervention of choice by experts Class IIb: acceptable, safe and useful, within standard of care, optional or alternative by experts Interderminate: inadequate research to decide Class III: evidence for benefit lacking, or harmful Chain of Survival • • • • • • Recognize early warning signs Activate EMS Basic CPR Defibrillation Airway and ventilation Intravenous medications Public Access Defibrillation: PAD • Goal: AEDs used by laypersons everywhere • Most effective cardiac intervention • Shown to be cost effective (cost per life year saved) • Response time goal is 3 to 5 minutes – Police – Fire – Casino – Airlines – First responders • Survival rates up to 49% from primary ventricular fibrillation Sequence of Events • 50% of patients with CAD first present with sudden death • Sequence: – Decades of atherosclerotic buildup – Plaque rupture or erosion – Platelet adhesion – Occluding thrombus – Severe ischemia – Irritable myocardium – Ventricular fibrillation – Collapse and sudden death Adult BLS: Recent Changes • Phone first (no CPR unless drowned, trauma or overdose) • BLS should transport to ED capable of IV thrombolysis for MI and stroke – Within 30 minutes for MI – Within 60 minutes for stroke BLS Sequence Changes • 10cc/kg tidal volume without oxygen • 6-7 cc/kg with supplemental oxygen • Prevent gastric insufflation: deliver over 2 seconds • Lay rescuers don’t check pulses before chest compressions, healthcare workers do • Compression rate 100/minute • 15:2 ratio for 1 and 2-rescuer CPR Prehospital Care for ACS • Oxygen is routine • Aspirin en route: 160-325mg • Nitroglycerin – – – – – Be careful with Viagra Need SBP >90 3 sprays q 3-5 minutes Morphine if 3 sprays don’t relieve pain 12 lead ECG under study Prehospital Stroke Care • Determine time of onset and GCS • Perform prehospital stroke scale – Cincinnati PSS: sensitivity 72% – Los Angeles PSS: 93% sensitivity, 97% specificity • LAPSS – Age > 45 – No seizures – Duration < 24 hours – Ambulatory at baseline – Glucose 60-400 – Obvious asymmetry of face/grip/arm strength ACLS Changes for 2000 • Wide complex tachycardia: Amiodarone and procainamide before lidocaine and adenosine (IIb) • Stable V tach (and torsades): Amiodarone and sotalol preferred (IIa) • Bretylium not available (IIb) • Lidocaine: evidence poor for benefit for vfib and v-tach (indeterminate) ACLS Changes for 2000 • V-fib/pulseless V-tach: evidence for all antiarrhythmics weak. Amiodarone preferred (IIb) • Magnesium still IIb for torsades de pointes (polymorphic ventricular tachycardia) • Vasopressin: may be more effective than epinephrine in cardiac arrest (IIb) – 40 units IV only once – Epinephrine still class IIb • High-dose epinephrine: no benefit (indeterminate) Defibrillation: Biphasic • Will become the norm • As effective at lower energy – 150 biphasic = 200 monophasic – No need for escalating energy levels (joules) • Transthoracic impedance declines with subsequent shocks • Repeat same energy = success Shock Energies: Recommended • Still 200/200-300/360 joules for v-fib /pulseless v-tach • Atrial fibrillation: 100-200 • Atrial flutter/PSVT 50 to start • Ventricular tachycardia – Monomorphic (usual) 100 joules – Polymorhpic (torsades de pointes) 200 joules Other Defibrillator Points: • Synchronize for any perfusing rhythm – Avoids precipitating ventricular fibrillation – Hold buttons down • Check two leads for asystole – If no ventricular fibrillation noted, defibrillation not effective • Lead disconnect can simulate asystole Cardiac Arrhythmias • Check the patient, not the rhythm • Perfusion is most important • Wide complex tachycardias are ventricular tachycardia – Odds 75/25 ventricular/supraventricular – Older (>45 yo) – Sicker (previous MI or coronary disease) – Treat the worst, first • 12 ECG criteria not reliable enough to distinguish Rhythms to recognize • Normal sinus rhythm • Atrio-ventricular (AV) blocks – 1st degree(not important) – 2nd degree • Type I (Wenkebach) • Type II (dangerous) – 3rd degree (complete, AV disassociation) • Premature complexes – Atrial (no pause) – Ventricular (compensatory pause) Rhythms to Recognize • Ventricular tachycardia – Monomorphic – Polymorphic (Torsades de pointe) • Ventricular fibrillation • Asystole (confirm) Tachyarrhythmias • Narrow QRS complex (<120 msec) – – – – – – – Sinus Atrial fibrillation Atrial flutter Atrial tachycardia (digoxin toxicity) Multifocal atrial tachycardia (COPD) AV nodal re-entrant tachycardia (PSVT) Junctional tachycardia Tachyarrhythmias • Wide QRS (>120 msec) – Ventricular tachycardia (usually 160 msec) – Supraventricular tachycardia with aberrant conduction (usually not this wide) • 12 lead if stable • Mr. Edison if not Show Rhythm Strips Routes for Drug Administration • Evidence for effectiveness for all drugs is weak • Drugs are secondary interventions • Peripheral still first choice – flush with NS – 1-2 minutes to central circulation • If no response to drugs and defibrillation – Consider central line • Internal jugular (IJ) preferred (or supraclavicular subclavian) • Femoral less preferred – Avoid non-compressible sites if possible Tracheal Administration • N-a-v-e-l still holds: drugs for the ET tube – Narcan – Atropine – Valium – Epinephrine – Lidocaine • Amiodarone/vasopressin not yet studied, so avoid • Dilute in 10cc/bag vigorously • 2-2.5 times the IV dose for all meds Wide Complex Tachycardias: Stable • Must be regular and fast (>120) • Must be uniform (one QRS morphology) • No signs of impaired perfusion – – – – Mental status normal No chest pain or CHF Skin signs warm and dry Systolic BP > 90 mm Hg • Obtain 12 lead ECG if stable Wide Complex Tachycardias: Stable • Procainamide first line if ventricular function normal (sotalol) (both IIa) • Amiodarone (IIb) (150mg over 10 minutes) or Lidocaine (.5-.75mg/kg IVP) if poor EF (<40%) • If ineffective: – Synchronized cardioversion (100/200/300/360 joules) – No repeat drug doses recommended • Bottom line: – Normotensive: procainamide – Hypotensive: cardiovert Polymorphic Ventricular Tachycardia • Recurrent bouts • • • • – Usually terminate spontaneously, or – Degenerate into v-fib Stop offending meds that prolong QT interval Correct hyopcalcemia/hypomagnesemia Magnesium 2-4 grams IVP (shortens QT) Transcutaneous pacer (“overdrive pacing”) – Rate >100 if no ischemia – Shortens QT, reduces recurrence V-fib/Pulseless V-tach • • • • • This is easy! Defib three times ASAP (200/300/360) ABCs Epi 1mg IV every 3-5 minutes, or Vasopressin 40 units IVP, once – Then Epi same as usual • Amiodarone (IIb) 300mg IVP (second dose if recurrent V-fib 150 mg) Look for Cause! • Hypovolemia • Hypoxia • • • • • • – ETT/02 hooked up/pneumothorax/CO poisoning Acidosis Hypo/hyperkalemia Cardiac tamponade Tension pneumothorax Coronary thrombosis Massive pulmonary embolism Langdorf’s Silly Mnemonic • • • • • • • • • • Shock, shock, shock (defibrillation three times) All Breathing Counts (airway, breathing, circulation) EVerybody (epinephrine OR vasopressin) Shocks (defib) Americans (amiodarone) Shock (defib) Europeans (epinephrine again) Shock (defib) Latin Americans (lidocaine) Shock (defib) Sodium Bicarbonate: Indications • • • • • • • • No changes Hyperkalemia (class I) Pre-existing acidosis (class IIa) TCA overdose (class IIa) ASA overdose (class IIa) Prolonged arrest (class IIb) Return of spontaneous circulation (class IIb) NOT in hypoxic, lactic acidosis cardiac arrest! Pressors: Epinephrine • • • • • • Alpha effects confer benefit Increases systemic vascular resistance Increases aortic root pressure Perfuses coronaries Perfuses brain at expense of body Escalating or high doses without demonstrable benefit • Potent pressor for hypotension (1mg in 500cc at 210 micrograms/min) Pressors: Norepinephrine • • • • Potent alpha and beta agonist Indicated for severe hypotension (SBP < 70) Dose 1-30 micrograms/min Extravasation: infiltrate 5-10 mg of phentolamine Pressors: Dopamine • Precursor of norepinephrine • Alpha and beta adrenergic agonist • Indicated with hypotension and bradycardia (raises SBP and HR) • Dose 5-20 micrograms/min after cardiac arrest – 5-10 primarily beta stimulation – 10-20 additional potent alpha effect Pressors: Dobutamine • Potent beta-1 selective ventricular inotrope • Use for severe systolic dysfunction • Reflex tachycardia due to peripheral vasodilation • 5-20 micrograms/min